CNS‐irrelevant T‐cells enter the brain, cause blood–brain barrier disruption but no glial pathology
暂无分享,去创建一个
J. Wuerfel | E. Tysiak | F. Zipp | R. Nitsch | J. Vogt | E. Pohl | S. Hendrix | C. Infante-Duarte | A. Smorodchenko | R. Glumm
[1] Jens Wuerfel,et al. Targeting activated microglia in Alzheimer's pathology by intraventricular delivery of a phagocytosable MRI contrast agent in APP23 transgenic mice , 2009, NeuroImage.
[2] G. Stoll,et al. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. , 2008, Brain : a journal of neurology.
[3] F. Paul,et al. Perivascular spaces--MRI marker of inflammatory activity in the brain? , 2008, Brain : a journal of neurology.
[4] M. Filippi,et al. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives , 2008, Multiple sclerosis.
[5] Frederik Barkhof,et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.
[6] J. Kreuter,et al. Use of nanoparticles for cerebral cancer. , 2008, Tumori.
[7] P. Adriaensens,et al. Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging , 2008, Journal of Neuroimmunology.
[8] Frauke Zipp,et al. Mouse model mimics multiple sclerosis in the clinico‐radiological paradox , 2007, The European journal of neuroscience.
[9] P. Trouillas,et al. Inflammatory Response After Ischemic Stroke: A USPIO-Enhanced MRI Study in Patients , 2007, Stroke.
[10] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[11] Ulrich Dirnagl,et al. Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging , 2006, NeuroImage.
[12] C. Förster,et al. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli , 2006, Journal of Neuroimmunology.
[13] J. Frank,et al. Cellular magnetic resonance imaging: current status and future prospects , 2006, Expert review of medical devices.
[14] B. Becher,et al. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain , 2006, Journal of Molecular Medicine.
[15] W. Pan,et al. Receptor-mediated transport of LIF across blood–spinal cord barrier is upregulated after spinal cord injury , 2006, Journal of Neuroimmunology.
[16] J. Caillé,et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. , 2006, AJNR. American journal of neuroradiology.
[17] D. Goodin. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment? , 2006, Annals of neurology.
[18] B. Engelhardt. Molecular mechanisms involved in T cell migration across the blood–brain barrier , 2006, Journal of Neural Transmission.
[19] Markus Rudin,et al. Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood‐brain barrier damage , 2006, NMR in biomedicine.
[20] E. Radue,et al. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. , 2005, AJR. American journal of roentgenology.
[21] A. Arbab,et al. Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells , 2005, NMR in biomedicine.
[22] Tobias Bonhoeffer,et al. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion , 2005, The Journal of experimental medicine.
[23] I. Bechmann,et al. Neuronal Damage in Autoimmune Neuroinflammation Mediated by the Death Ligand TRAIL , 2005, Neuron.
[24] J. Russell,et al. Defining antigen‐dependent stages of T cell migration from the blood to the central nervous system parenchyma , 2005, European journal of immunology.
[25] M. Pender,et al. Blood–brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement , 2005, Journal of Neuroimmunology.
[26] Peter M. Jakob,et al. In vivo detection limits of magnetically labeled embryonic stem cells in the rat brain using high-field (17.6 T) magnetic resonance imaging , 2005, NeuroImage.
[27] R. Banati,et al. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease , 2004, Brain Research Reviews.
[28] M. Rausch,et al. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide‐enhanced magnetic resonance imaging , 2004, Journal of magnetic resonance imaging : JMRI.
[29] B. Hamm,et al. Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging , 2004, Investigative radiology.
[30] Andreas Saleh,et al. In vivo MRI of brain in ̄ ammation in human ischaemic stroke , 2004 .
[31] R. Shivers,et al. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. , 2004, Histology and histopathology.
[32] F. Zipp,et al. Direct Impact of T Cells on Neurons Revealed by Two-Photon Microscopy in Living Brain Tissue , 2004, The Journal of Neuroscience.
[33] K. Nicolay,et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. , 2004, Brain : a journal of neurology.
[34] Alireza Minagar,et al. Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.
[35] G. Stoll,et al. Caught in the Act: In Vivo Mapping of Macrophage Infiltration in Nerve Injury by Magnetic Resonance Imaging , 2003, The Journal of Neuroscience.
[36] M. Rausch,et al. MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE , 2003, Magnetic resonance in medicine.
[37] Jeff W M Bulte,et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. , 2003, Radiology.
[38] M. Carson. Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis , 2002, Glia.
[39] M. Taupitz,et al. In Vitro Characterization of Two Different Ultrasmall Iron Oxide Particles for Magnetic Resonance Cell Tracking , 2002, Investigative radiology.
[40] M. Rausch,et al. In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO , 2002, NMR in biomedicine.
[41] F. Barkhof. The clinico‐radiological paradox in multiple sclerosis revisited , 2002, Current opinion in neurology.
[42] M. Filippi. Predictive value of MRI findings in multiple sclerosis , 2002, The Lancet Neurology.
[43] Bernd Hamm,et al. Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging: Preclinical In Vivo Characterization , 2002, Investigative radiology.
[44] W. Hickey. Basic principles of immunological surveillance of the normal central nervous system , 2001, Glia.
[45] I. Bechmann,et al. Th2 cells support intrinsic anti-inflammatory properties of the brain , 2001, Journal of Neuroimmunology.
[46] Robbie Robertson,et al. Comparison of the timing of acute blood‐brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis , 2001, The Journal of comparative neurology.
[47] J. Goverman,et al. In Situ Tolerance within the Central Nervous System as a Mechanism for Preventing Autoimmunity , 2000, The Journal of experimental medicine.
[48] J. Pollard,et al. Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity. , 2000, The American journal of pathology.
[49] M. Ueno,et al. Blood-brain barrier permeability in the periventricular areas of the normal mouse brain , 2000, Acta Neuropathologica.
[50] Klaus G. Petry,et al. Dose and scanning delay using USPIO for central nervous system macrophage imaging , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.
[51] J. Pollard,et al. Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies. , 1999, Brain : a journal of neurology.
[52] C Delalande,et al. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. , 1999, AJNR. American journal of neuroradiology.
[53] Tomoko Nakanishi,et al. ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.
[54] H. G. Eijk,et al. Transcytosis of 6.6-nm gold-labeled transferrin: an ultrastructural study in cultured porcine blood–brain barrier endothelial cells , 1997, Brain Research.
[55] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[56] W. Brück,et al. Macrophages in multiple sclerosis. , 1996, Immunobiology.
[57] J. Prineas,et al. Blood‐Brain Barrier Abnormalities in Longstanding Multiple Sclerosis Lesions. An Immunohistochemical Study , 1994, Journal of neuropathology and experimental neurology.
[58] C. Koh,et al. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease , 1993, Journal of Neuroimmunology.
[59] Roland Martin,et al. Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.
[60] Y. Matsumoto,et al. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system , 1992, Journal of Neuroimmunology.
[61] W. Hickey,et al. T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.
[62] C. Brosnan,et al. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells. , 1990, The American journal of pathology.
[63] V. ter meulen,et al. Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and nonencephalitogenic CD4+ T cell lines in vitro. , 1990, Journal of immunology.
[64] B E Kendall,et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.
[65] C. Brosnan,et al. Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. , 1989, The American journal of pathology.
[66] P. Isaacson,et al. Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.
[67] H I Goldberg,et al. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. , 1988, Radiology.
[68] H. Lassmann,et al. Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.
[69] C. Brosnan,et al. Astrocytic reactivity and intermediate filament metabolism in experimental autoimmune encephalomyelitis: The effect of suppression with prazosin , 1986, Brain Research.
[70] J. Iles,et al. Motor neuron columns in the lumbar spinal cord of the rat , 1983, The Journal of comparative neurology.
[71] H. Klüver,et al. A method for the combined staining of cells and fibers in the nervous system. , 1953, Journal of neuropathology and experimental neurology.
[72] K. Abromeit. Music Received , 2023, Notes.
[73] V. Perry,et al. What is the blood-brain barrier (not)? , 2007, Trends in immunology.
[74] Frauke Zipp,et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.
[75] D. Perl,et al. Comparative techniques for determining cellular iron distribution in brain tissues , 1992, Annals of neurology.
[76] L. Eng,et al. Glial fibrillary acidic protein in chronic relapsing experimental allergic encephalomyelitis in SJL/J mice , 1987, Journal of neuroscience research.